D.D. Matsakova

D.D. Matsakova

Auto-generated profile, based on publicly available information

D.D. Matsakova

Immanuel Kant Baltic Federal University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2025 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
APA.I. Pashov
A.I. Pashov
DMD.D. Matsakova
D.D. Matsakova
LVLarisa Vladimirovna Volkova
Larisa Vladimirovna Volkova
VRV.V. Rachkovskaya
V.V. Rachkovskaya
ATA.S. Turdieva
A.S. Turdieva
This article raises current issues of the use of gonadotropin-releasing hormone (GnRH) in women suffering from hyperplastic conditions in gynecology. Such diseases include: uterine fibroids, endometriosis, endometrial hyperplasia, and endometrial cancer. The article pays special attention to the pathophysiological aspects of the action of this hormone, reveals its positive pharmacological properties, as well as negative, undesirable properties (side effects). Some etiopathogenetic aspects of the development of hyperplastic diseases in gynecology and the points of influence of GnRH on them are touched upon. This article examines the general principles of pharmacological treatment of hyperplastic processes with GnRH, and also compares it with other drugs: the advantages and disadvantages of treatment methods are described.